InvestorsHub Logo
Followers 4
Posts 702
Boards Moderated 0
Alias Born 05/19/2016

Re: McMagyar post# 81826

Saturday, 12/03/2016 10:52:54 AM

Saturday, December 03, 2016 10:52:54 AM

Post# of 462437
Thanks for the info.

I think you may be right. When the 6-month data came out many were disappointed at the "leveling off" of efficacy with patients who were dual therapy. I thought just the opposite. Maybe the other med was competing or interfering with 2-73. I thought 2-73 would continue to do better on its own. Maybe that's just what happened!

Hope it turns out as good as it appears!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News